Cystic degeneration of a fibroid in the context of abnormal uterine bleeding in young patients: a case report

Noé Alonso Juárez Menéndez; Cinthia Nallely Arguelles Castillo; Carolina Tapia Navarro; Juan Armando Reyes Hernández; Alejandro García Peña; Rodolfo Padrón Martínez; Alan Isaac Valderrama-Treviño

doi:10.18203/2349-2902.isj20252888

Authors

Noé Alonso Juárez Menéndez Department of Diagnostic and Therapeutic Imaging. Dr. Manuel Gea González General Hospital, Mexico City
Cinthia Nallely Arguelles Castillo Department of Diagnostic and Therapeutic Imaging. Dr. Manuel Gea González General Hospital, Mexico City
Carolina Tapia Navarro 1. Department of Diagnostic and Therapeutic Imaging. Dr. Manuel Gea González General Hospital. Mexico City.
Juan Armando Reyes Hernández Department of Diagnostic and Therapeutic Imaging. Dr. Manuel Gea González General Hospital, Mexico City
Alejandro García Peña Department of Diagnostic and Therapeutic Imaging. Dr. Manuel Gea González General Hospital, Mexico City
Rodolfo Padrón Martínez Department of Diagnostic and Therapeutic Imaging. Dr. Manuel Gea González General Hospital, Mexico City
Alan Isaac Valderrama-Treviño Department of Angiology, Vascular and Endovascular Surgery, Hospital Ángeles Roma, Mexico City

DOI:

https://doi.org/10.18203/2349-2902.isj20252888

Keywords:

Abnormal uterine bleeding, Uterine fibroid, Hydatidiform mole, Ultrasound, Beta-HCG, Pelvic mass

Abstract

Uterine fibroids are the most common uterine tumors in perimenopausal women; their presence and growth are associated with elevated estrogen levels and stimulation of progesterone receptors. Clinically, fibroids are associated with abnormal uterine bleeding, anemia, recurrent pregnancy loss, infertility, and/or chronic pelvic pain. Ultrasound imaging faces challenges when fibroids present atypical features. Degenerated fibroids in their cystic variant are related to edema and multiple intrauterine cysts. In young patients, obstetric pathology should not be overlooked. The easy accessibility and low cost of ultrasound allow for universal screening of patients with abnormal uterine bleeding. The pathognomonic presence of a "cluster of grapes" pattern raises suspicion of molar pregnancy in this patient population. It is essential to establish an accurate diagnosis to initiate appropriate therapeutic management, prognosis, and follow-up. Gynecologists and sonographers should consider the β-hCG hook effect or receptor saturation, which may produce false-negative results, as well as recognize the degenerative variants of uterine fibroids to accurately raise diagnostic suspicion.

Metrics

Metrics Loading ...

References

American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No 96: Alternatives to hysterectomy in the management of leiomyomas. Obstet Gynecol. 2008;112(1):387–400. DOI: https://doi.org/10.1097/AOG.0b013e318183fbab

Anyanwu M, Gassama K, Kandeh M. Diagnostic dilemma of hyaline cystic degeneration of uterine fibroids. Obstet Gynecol Int J. 2019;10(3):202–5. DOI: https://doi.org/10.15406/ogij.2019.10.00444

Babacan A, Kizilaslan C, Gun I, Muhcu M, Mungen E, Atay V. CA 125 and other tumor markers in uterine leiomyomas and their association with lesion characteristics. Int J Clin Exp Med. 2014;7(4):1078–83.

Coyle C, Short D, Jackson L, Sebire NJ, Kaur B, Harvey R, et al. What is the optimal duration of human chorionic gonadotrophin surveillance following evacuation of a molar pregnancy. A retrospective analysis on over 20 000 consecutive patients. Gynecol Oncol. 2018;148(2):254–7. DOI: https://doi.org/10.1016/j.ygyno.2017.12.008

Ghassemzadeh S, Farci F. Hydatidiform Mole. In: StatPearl. Treasure Island (FL): StatPearls Publishing. 2025.

Cunningham RK, Horrow MM, Smith RJ, Springer J. Adenomyosis: a sonographic diagnosis. Radiographics. 2018;38(5):1576–89. DOI: https://doi.org/10.1148/rg.2018180080

Dibaba AD, Ljani N, Mustafa A, Khanbhai H, Ntungi A, Secha A, et al. Complete cystic degeneration of a uterine myoma posing a diagnostic dilemma. Case Rep Radiol. 2025;2:5627017. DOI: https://doi.org/10.1155/crra/5627017

Gonzalez J, Popp M, Ocejo S, Abreu A, Bahmad HF, Poppiti R. Gestational trophoblastic disease: complete versus partial hydatidiform moles. Diseases. 2024;12(3):159. DOI: https://doi.org/10.3390/diseases12070159

Hui P. Germline NLRP7 mutations: genomic imprinting and hydatidiform mole. Virchows Arch. 2020;476(2):175–6. DOI: https://doi.org/10.1007/s00428-020-02802-y

Kaushik C, Prasad A, Singh Y, Baruah BP. Case series: cystic degeneration in uterine leiomyomas. Indian J Radiol Imaging. 2008;18(1):69–72. DOI: https://doi.org/10.4103/0971-3026.35820

Kim HJ, Lee WY, Kim YH, Jin HJ, Jeong MJ, Cho HJ, et al. Effects of phthalate esters on human myometrial and fibroid cells: cell culture and NOD-SCID mouse data. Reprod Sci. 2021;28(2):479–87. DOI: https://doi.org/10.1007/s43032-020-00341-0

Lin Y, Wu RC, Huang YL, Lin CR, Yu MH, Liu YH, et al. Uterine fibroid-like tumors: spectrum of MR imaging findings and their differential diagnosis. Abdom Radiol (NY). 2022;47(6):2197–208. DOI: https://doi.org/10.1007/s00261-022-03431-6

Lobo Antunes I, Curado J, Quintas A, Pereira A. Negative β-hCG and molar pregnancy: the hook effect. Acta Med Port. 2017;30(9):656–8. DOI: https://doi.org/10.20344/amp.8603

Lukinovic N, Malovrh EP, Takac I, Sobocan M, Knez J. Advances in the diagnosis and treatment of gestational trophoblastic disease. Radiol Oncol. 2022;56(4):430–9. DOI: https://doi.org/10.2478/raon-2022-0038

Madueke-Laveaux OS, Elsharoud A, Al-Hendy A. What we know about the long-term risks of hysterectomy for benign indication: a systematic review. J Clin Med. 2021;10(24):5335. DOI: https://doi.org/10.3390/jcm10225335

Mension E, Calaf J, Chapron C, Dolmans MM, Donnez J, Marcellin L, et al. An update on the management of uterine fibroids: personalized medicine or guidelines. J Endometr Uterine Disord. 2024;7(1):100080. DOI: https://doi.org/10.1016/j.jeud.2024.100080

Morena López M, Vallejo Ribera SR, Valbuena Durán EJ, Bonilla López L, Jiménez Relimpio C, López Ruiz L, et al. Assessment of uterine fibroids: what the radiologist should know. SERAM. 2024.

Ngan HYS, Seckl MJ, Berkowitz RS, Xiang Y, Golfier F, Sekharan PK, et al. Update on the diagnosis and management of gestational trophoblastic disease. Int J Gynaecol Obstet. 2015;131(2):123–6. DOI: https://doi.org/10.1016/j.ijgo.2015.06.008

Nougaret S, Nikolovski I, Paroder V, Vargas HA, Sala E, Carrere S, et al. MRI of tumors and tumor mimics in the female pelvis: anatomic pelvic space-based approach. Radiographics. 2019;39(4):1205–29. DOI: https://doi.org/10.1148/rg.2019180173

Okizuka H, Sugimura K, Takemori M, Obayashi C, Kitao M, Ishida T. MR detection of degenerating uterine leiomyomas. J Comput Assist Tomogr. 1993;17(5):760–6. DOI: https://doi.org/10.1097/00004728-199309000-00018

Pavone D, Clemenza S, Sorbi F, Fambrini M, Petraglia F. Epidemiology and risk factors of uterine fibroids. Best Pract Res Clin Obstet Gynaecol. 2018;46:3–11. DOI: https://doi.org/10.1016/j.bpobgyn.2017.09.004

Baasanjav B, Usui H, Kihara M, Kaku H, Nakada E, Tate S, et al. The risk of post-molar gestational trophoblastic neoplasia is higher in heterozygous than in homozygous complete hydatidiform moles. Hum Reprod. 2010;25(5):1183–91. DOI: https://doi.org/10.1093/humrep/deq052

Winarto H, Simatupang ONN, Calvin D, Siregar TP, Andrijono. Diagnostic challenge: distinguishing uterine fibroid with cystic degeneration vs. ovarian cystic malignancy. J Radiol Case Rep. 2023;17(4):1–12. DOI: https://doi.org/10.3941/jrcr.v17i4.4583